194 related articles for article (PubMed ID: 4626510)
1. Human immunity to Pseudomonas aeruginosa. II. Relationship between heat-stable opsonins and type-specific lipopolysaccharides.
Young LS
J Infect Dis; 1972 Sep; 126(3):277-87. PubMed ID: 4626510
[No Abstract] [Full Text] [Related]
2. Heat-stable opsonins in sera of patients with Pseudomonas infections.
Crowder JG; Devlin HB; Fisher M; White A
J Lab Clin Med; 1974 Jun; 83(6):853-9. PubMed ID: 4417460
[No Abstract] [Full Text] [Related]
3. Factors in human serum promoting phagocytosis of Pseudomonas aeruginosa. II. Interaction of opsonins with the phagocytic cell.
Bjornson AB; Michael JG
J Infect Dis; 1974 Nov; 130 Suppl(0):S127-31. PubMed ID: 4214224
[No Abstract] [Full Text] [Related]
4. Factors in human serum promoting phagocytosis of Pseudomonas aeruginosa. I. Interaction of opsonins with the bacterium.
Bjornson AB; Michael JG
J Infect Dis; 1974 Nov; 130 Suppl(0):S119-26. PubMed ID: 4214223
[No Abstract] [Full Text] [Related]
5. Human immunity to Pseudomonas aeruginosa. I. In-vitro interaction of bacteria, polymorphonuclear leukocytes, and serum factors.
Young LS; Armstrong D
J Infect Dis; 1972 Sep; 126(3):257-76. PubMed ID: 4626509
[No Abstract] [Full Text] [Related]
6. Role of antibody in infections due to Pseudomonas aeruginosa.
Young LS
J Infect Dis; 1974 Nov; 130 Suppl(0):S111-8. PubMed ID: 4213568
[No Abstract] [Full Text] [Related]
7. Contribution of humoral and cellular factors to the resistance to experimental infection by Pseudomonas aeruginosa in mice. I. Interaction between immunoglobulins, heat-labile serum factors, and phagocytic cells in the killing of bacteria.
Bjornson AB; Michael JG
Infect Immun; 1971 Oct; 4(4):462-7. PubMed ID: 5005303
[TBL] [Abstract][Full Text] [Related]
8. Host defenses in patients with cystic fibrosis: modulation by Pseudomonas aeruginosa.
Speert DP
Surv Synth Pathol Res; 1985; 4(1):14-33. PubMed ID: 3927464
[No Abstract] [Full Text] [Related]
9. Contribution of humoral and cellular factors to the resistance to experimental infection by Pseudomonas aeruginosa in mice. II. Opsonic, agglutinative, and protective capacities of immunoglobulin G anti-Pseudomonas antibodies.
Bjornson AB; Michael JG
Infect Immun; 1972 May; 5(5):775-82. PubMed ID: 4629252
[TBL] [Abstract][Full Text] [Related]
10. Comparative studies on the protective potential of antisera directed against four antigenic preparations from Pseudomonas aeruginosa.
Johnston LJ; Syeklocha D
Can J Microbiol; 1972 Oct; 18(10):1607-11. PubMed ID: 4628185
[No Abstract] [Full Text] [Related]
11. Type-specific immunity in pseudomonas diseases.
Crowder JG; Fisher MW; White A
J Lab Clin Med; 1972 Jan; 79(1):47-54. PubMed ID: 4621414
[No Abstract] [Full Text] [Related]
12. Anti-Pseudomonas heat-stable opsonins in acute lymphoblastic leukemia of childhood.
Wollman MR; Young LS; Armstrong D; Haghbin M
J Pediatr; 1975 Mar; 86(3):376-81. PubMed ID: 803559
[TBL] [Abstract][Full Text] [Related]
13. Cystic fibrosis pseudomonas opsonins. Inhibitory nature in an in vitro phagocytic assay.
Fick RB; Naegel GP; Matthay RA; Reynolds HY
J Clin Invest; 1981 Oct; 68(4):899-914. PubMed ID: 6793632
[TBL] [Abstract][Full Text] [Related]
14. Pseudomonas endocarditis: hemagglutinating antibodies to Fisher-Devlin-Gnabasik immunotypes in sera.
Reyes MP; Fisher MW; Lerner AM
J Lab Clin Med; 1974 Jun; 83(6):845-52. PubMed ID: 4213766
[No Abstract] [Full Text] [Related]
15. Bacterial blocking activity of specific IgG in chronic Pseudomonas aeruginosa infection.
Guttman RM; Waisbren BA
Clin Exp Immunol; 1975 Jan; 19(1):121-30. PubMed ID: 54231
[TBL] [Abstract][Full Text] [Related]
16. Opsonic and protective activity of five human IgM monoclonal antibodies reactive with lipopolysaccharide antigen of Pseudomonas aeruginosa.
Collins MS; Ladehoff DK; Mehton NS; Noonan JS
FEMS Microbiol Immunol; 1990 Dec; 2(5-6):263-8. PubMed ID: 2127368
[TBL] [Abstract][Full Text] [Related]
17. [Immunologic study of the cellular components of pseudomonas pyocyaneus. II. Extraction of purified lipopolysaccharide, its characteristics and elaboration of an erythrocyte O-diagnosticum].
Kolker II; Stanislavskiĭ ES; Zarubina EK; Elagina EK; Kaliaev AV
Zh Mikrobiol Epidemiol Immunobiol; 1976; (12):113-07. PubMed ID: 828824
[TBL] [Abstract][Full Text] [Related]
18. IgG subclasses and chronic bacterial infection. Subclass antibodies and the clinical course of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis.
Pressler T
APMIS Suppl; 1996; 66():1-41. PubMed ID: 8972694
[No Abstract] [Full Text] [Related]
19. Double gel diffusion studies on Pseudomonas aeruginosa O antigens.
Lányi B; Adám MM
Acta Microbiol Acad Sci Hung; 1973; 20(4):337-46. PubMed ID: 4211937
[No Abstract] [Full Text] [Related]
20. Complement deposition by antibodies to Pseudomonas aeruginosa mucoid exopolysaccharide (MEP) and by non-MEP specific opsonins.
Pier GB; Grout M; Desjardins D
J Immunol; 1991 Sep; 147(6):1869-76. PubMed ID: 1832427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
